ENTITY
Shanghai HeartCare Medical Technology

Shanghai HeartCare Medical Technology (6609 HK)

36
Analysis
Health Care • China
Engages in research, development, manufacture and sale of neuro-interventional medical devices
more
•18 Oct 2021 15:33

MicroTech Medical IPO: Thoughts on First Day Trading

MicroTech priced its IPO at HK$30.50 per share which significantly overvalues the shares. We expect the company's shares to open poorly at its...

Share
bearish•Broncus
•23 Sep 2021 19:19

Broncus IPO: Thoughts on First Day Trading

Though Broncus priced its IPO at the top-end of its price range, our reverse DCF model suggests that Broncus’ IPO is overvalued. We expect shares...

Share
bearish•Broncus
•23 Sep 2021 11:42

Broncus (å ƒåšåŒ»ē–—) IPO Trading: Chilled for a Reason but Mind the Share Concentration

We look at the updates since our last note for Broncus IPO. We re-iterate our view that the company is fairly valued at the top end and will stay...

Logo
444 Views
Share
bearish•Acotec Scientific
•23 Aug 2021 10:43

Acotec (å…ˆē‘žč¾¾) IPO Trading: Expect Poor Debut Performance

We look at the updates of Acotec IPO since our last note. We think the institutional demand is week for the price and we re-iterate our view that...

Logo
311 Views
Share
•22 Aug 2021 10:21

ECM Weekly (22nd August 2021) - Biel Crystal, EDDA, Neusoft Xikang and Medical, CATL, RLC REIT

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
x